Qube Research & Technologies Ltd - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,783,099
+6.2%
59,318
+28.0%
0.01%
-14.3%
Q1 2023$1,678,391
+46.2%
46,326
+44.0%
0.01%
+16.7%
Q4 2022$1,147,682
+120.7%
32,175
+109.3%
0.01%
+100.0%
Q3 2022$520,000
-65.5%
15,369
-70.3%
0.00%
-75.0%
Q4 2021$1,509,000
+506.0%
51,750
+394.1%
0.01%
+200.0%
Q2 2020$249,000
+29.7%
10,474
-2.1%
0.00%
-50.0%
Q1 2020$192,000
-77.0%
10,699
-69.7%
0.01%
-69.2%
Q4 2019$836,00035,2620.03%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders